Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,595.3
32.1 (1.25%)

 

  • STI Straits Times Index
    2,595.3
    32.1 (1.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,569.7
    13.1 (0.84%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,215.6
    -28.4 (-0.11%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,322.8
    3.6 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,272.3
    428.4 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,229.8
    -3.7 (-0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 668.7M
  • Value: 632.7M
  • Rise: 210
  • Fall: 70
  • Unch: 528

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.026+0.008
Medtecs Intl1.570+0.160
QT Vascular0.008+0.001
ThaiBev0.610+0.010
Sembcorp Marine0.245-0.105
UMS1.170+0.090
Rex Intl0.184+0.002
Genting Sing0.725+0.020
IPS Securex0.117+0.005
YZJ Shipbldg SGD0.960+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

10X GENOMICS INC 10X GENOMICS INC
Updated on 12 Aug 2020 (End of trading day)
Last (USD): 97.510 Change: +0.610 High: 99.490 Remarks: -
Change (%): +0.63 Low: 92.540
Open 97.020 Yesterday's Close 96.9
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,572,180 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.31273 Trailing EPS (USD) e -0.48792 NAV (USD) b 4.0936
PE a - Trailing PE f - Price / NAV b 23.8201
Dividend (USD) d - Cash In Hand (USD) g 3.7269 Issued & Paid-up Shares c 57,934,400
Dividend Yield (%) d - Price / Cash In Hand g 26.164 Treasury Shares h -
Market Cap (M) 9,744.155 Enterprise Value (M) 9,431.346
Piotroski F Score 5 Exchange Code TXG Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 76.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 Sep 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference 10X GENOMICS INC NASDAQ 9,744.155 - - 23.8201 -
Industry Biotechnology NASDAQ 2,796.433 438.295 6455.431 6.9965 0.664
Local Peer AMGEN INC NASDAQ 141,573.954 18.053 19.396 13.2821 2.423
Local Peer GILEAD SCIENCES INC NASDAQ 86,306.085 16.024 - 4.7876 3.697
Local Peer VERTEX PHARMACEUTICAL NASDAQ 70,547.487 59.948 33.904 9.3823 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,149.123 30.792 21.836 7.1929 -
Local Peer ILLUMINA INC NASDAQ 50,244.440 50.144 72.503 11.0113 -
Local Peer BIOGEN INC NASDAQ 46,420.538 7.883 7.832 4.1049 -
Local Peer MODERNA INC NASDAQ 27,431.688 - - 9.3087 -
Local Peer SEATTLE GENETICS INC NASDAQ 27,628.984 - - 15.2303 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,526.601 9.369 26.624 2.1473 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 21,402.927 - 175.064 6.6126 -
Local Peer INCYTE CORPORATION NASDAQ 20,605.820 46.108 - 8.7886 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 19,195.242 - - 7.5682 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), VAXCYTE INC (NASDAQ), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ARVINAS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PASSAGE BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), PERSONALIS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AGENUS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), ARDELYX INC (NASDAQ), GERON CORP (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), XBIOTECH INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), KAMADA (NASDAQ), MERUS B V (NASDAQ), MANNKIND CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), TREVENA INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AFFIMED N V (NASDAQ), MEDICINOVA INC (NASDAQ), NEXTCURE INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), VERASTEM INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), XOMA CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), INMUNE BIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), INFLARX N V (NASDAQ), SESEN BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), VACCINEX INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), RESTORBIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), OCUGEN INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), COHBAR INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), CURIS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), SOLIGENIX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 127,919.225 47.679 44.159 14.7911 0.941
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 222,282.746 193.362 193.362 15.5437 -
Global Peer SINO BIOPHARM HKEx 173,061.742 56.386 56.902 4.9951 0.579
Global Peer BEIGENE HKEx 149,798.400 - - 7.6205 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 6,857.479 125.825 40.267 5.7203 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 29,440.097 - - 9.8700 -
Global Peer 3SBIO HKEx 23,146.305 20.964 20.964 2.1498 -
Global Peer HAOHAI BIOTEC HKEx 18,474.754 43.942 43.942 3.1410 0.737
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), MESOBLAST LTD (ASX), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), PFENEX INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), IBIO INC (NYSE American), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ANTEOTECH LIMITED (ASX), MEMPHASYS LTD (ASX), IMMUTEP LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), INVEX THERAPEUTICS LTD NPV (ASX), CYNATA THERAPEUTICS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIOTRON (ASX), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), BIONOMICS LTD (ASX), BIOSINO BIO-TEC (HKEx), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), HAO WEN H-NEW (HKEx), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.700
-1.71 %
10 Days ---
20 Days -+8.320
+9.33 %
Medium Term Return 3 Months -+18.540
+23.48 %
6 Months -+10.740
+12.38 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 45.110 - 108.359 Change From 1 Year Low +52.400 % Change From 1 Year Low (%) +116.16
Change From 1 Year High -10.848 % Change From 1 Year High (%) -10.01
2 Years Range 45.110 - 108.359 Change From 2 Years Low +52.400 % Change From 2 Years Low (%) +116.16
Change From 2 Years High -10.848 % Change From 2 Years High (%) -10.01
5 Years Range 45.110 - 108.359 Change From 5 Years Low +52.400 % Change From 5 Years Low (%) +116.16
Change From 5 Years High -10.848 % Change From 5 Years High (%) -10.01
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
12 Aug 2020 97.020 99.490 92.540 97.510 1,572,180 -
11 Aug 2020 96.690 98.280 94.490 96.900 537,588 -
10 Aug 2020 96.240 97.440 96.050 96.900 498,055 -
07 Aug 2020 98.900 99.300 95.380 96.130 609,380 -
06 Aug 2020 99.900 100.829 98.970 99.210 206,329 -
05 Aug 2020 99.790 100.200 99.000 100.000 382,297 -
04 Aug 2020 98.750 100.000 97.210 99.030 273,300 -
03 Aug 2020 99.000 101.460 98.025 99.010 890,517 -
31 Jul 2020 97.960 98.480 95.820 98.370 926,813 -
30 Jul 2020 96.510 98.790 94.710 97.510 679,140 -
29 Jul 2020 95.950 99.470 95.860 98.880 702,236 -
28 Jul 2020 96.720 98.730 95.153 95.500 547,888 -
27 Jul 2020 94.990 96.420 94.480 95.810 521,317 -
24 Jul 2020 95.760 95.760 93.120 94.650 427,500 -
23 Jul 2020 95.800 96.860 94.845 95.850 492,391 -
22 Jul 2020 95.480 96.880 93.580 94.610 256,492 -
21 Jul 2020 93.100 95.270 91.860 95.210 2,306,804 -
20 Jul 2020 91.900 94.480 91.520 93.000 573,363 -
17 Jul 2020 89.520 92.500 88.570 91.870 329,218 -
16 Jul 2020 90.150 90.810 87.750 89.190 195,775 -
15 Jul 2020 90.070 91.380 88.580 90.930 254,305 -
14 Jul 2020 86.190 89.240 85.740 88.910 496,336 -
Summary
Current 2 Weeks
(30 Jul 2020 to 12 Aug 2020)		 96.510 101.460 92.540 97.510 6,575,599 -
Previous 2 Weeks
(16 Jul 2020 to 29 Jul 2020)		 90.150 101.460 87.750 98.880 6,352,984 -
4 Weeks from
(17 Jun 2020 to 15 Jul 2020)		 89.470 101.460 87.845 90.930 19,081,202 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.